INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 129 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $292 | -92.4% | 752 | -50.0% | 0.00% | – |
| Q2 2023 | $3,833 | +101.0% | 1,504 | +266.8% | 0.00% | – |
| Q1 2023 | $1,907 | +6475.9% | 410 | -93.5% | 0.00% | -100.0% |
| Q4 2022 | $29 | -99.9% | 6,263 | +19.0% | 0.00% | 0.0% |
| Q3 2022 | $25,000 | +127.3% | 5,263 | +128.8% | 0.00% | – |
| Q2 2022 | $11,000 | -21.4% | 2,300 | -18.1% | 0.00% | – |
| Q1 2022 | $14,000 | +366.7% | 2,810 | +451.0% | 0.00% | – |
| Q4 2021 | $3,000 | -57.1% | 510 | -46.9% | 0.00% | – |
| Q3 2021 | $7,000 | -94.3% | 960 | -92.7% | 0.00% | -100.0% |
| Q2 2021 | $122,000 | +577.8% | 13,118 | +581.1% | 0.00% | – |
| Q1 2021 | $18,000 | 0.0% | 1,926 | -5.4% | 0.00% | -100.0% |
| Q4 2020 | $18,000 | -71.9% | 2,035 | -62.8% | 0.00% | -75.0% |
| Q3 2020 | $64,000 | +30.6% | 5,476 | +253.3% | 0.00% | 0.0% |
| Q2 2020 | $49,000 | +1125.0% | 1,550 | +181.8% | 0.00% | – |
| Q1 2020 | $4,000 | +100.0% | 550 | -60.0% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 1,375 | +77.4% | 0.00% | – |
| Q1 2019 | $3,000 | -66.7% | 775 | -65.2% | 0.00% | -100.0% |
| Q4 2018 | $9,000 | -47.1% | 2,225 | -25.2% | 0.00% | 0.0% |
| Q3 2018 | $17,000 | +54.5% | 2,975 | +8.2% | 0.00% | – |
| Q2 2018 | $11,000 | 0.0% | 2,750 | 0.0% | 0.00% | – |
| Q1 2018 | $11,000 | 0.0% | 2,750 | 0.0% | 0.00% | – |
| Q4 2017 | $11,000 | -35.3% | 2,750 | +1.9% | 0.00% | -100.0% |
| Q3 2017 | $17,000 | +88.9% | 2,698 | +135.0% | 0.00% | – |
| Q2 2017 | $9,000 | -10.0% | 1,148 | -25.8% | 0.00% | – |
| Q1 2017 | $10,000 | +11.1% | 1,548 | +19.3% | 0.00% | – |
| Q4 2016 | $9,000 | +12.5% | 1,298 | +44.2% | 0.00% | – |
| Q3 2016 | $8,000 | 0.0% | 900 | 0.0% | 0.00% | – |
| Q2 2016 | $8,000 | +166.7% | 900 | +16.1% | 0.00% | – |
| Q1 2016 | $3,000 | +50.0% | 775 | +129.3% | 0.00% | – |
| Q4 2015 | $2,000 | – | 338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |